Promising new CAR T cell therapy results in exceptional patient recovery - Earth News Report
Reviewed by Emily Henderson, B.Sc.Jul 15 2020 In a clinical trial evaluating a novel immunotherapy option for cancer treatment, a child with rhabdomyosarcoma, a form of muscle cancer, that had spread to the bone marrow, showed no detectable cancer following treatment with chimeric antigen receptor (CAR) T cells that were engineered to target the HER2
